Jalaluddin Mohammad Ashraf

Jalaluddin Mohammad Ashraf

Auto-generated profile, based on publicly available information

Jalaluddin Mohammad Ashraf

School of Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2016 in Scientific Reports
Verified
Journal Article
Open access
JAJalaluddin M Ashraf
Jalaluddin M Ashraf
MOHAMMAD AZAM ANSARIMOHAMMAD AZAM ANSARI
MOHAMMAD AZAM ANSARI
HKHaris M Khan
Haris M Khan
MAMohammad A Alzohairy
Mohammad A Alzohairy
ICInho Choi
Inho Choi
Advanced glycation end-products (AGEs) resulting from non-enzymatic glycation are one of the major factors implicated in secondary complications of diabetes. Scientists are focusing on discovering new compounds that may be used as potential AGEs inhibitors without affecting the normal structure and function of biomolecules. A number of natural and synthetic compounds have been proposed as AGE inhibitors. In this study, we investigated the inhibitory effects of AgNPs (silver nanoparticles) in AGEs formation. AgNPs (~30.5 nm) synthesized from Aloe Vera leaf extract were characterized using UV-Vis spectroscopy, energy-dispersive X-ray spectroscopy (EDX), high resolution-transmission electron microscopy, X-ray diffraction and dynamic light scattering (DLS) techniques. The inhibitory effects of AgNPs on AGEs formation were evaluated by investigating the degree of reactivity of free amino groups (lysine and arginine residues), protein-bound carbonyl and carboxymethyl lysine (CML) content and the effects on protein structure using various physicochemical techniques. The results showed that AgNPs significantly inhibit AGEs formation in a concentration dependent manner and that AgNPs have a positive effect on protein structure. These findings strongly suggest that AgNPs may play a therapeutic role in diabetes-related complications.

19 June 2014 in Glycobiology
Verified
Journal Article
Open access
PDF file
Saheem AhmadSaheem Ahmad
Saheem Ahmad
MKM. Salman Khan
M. Salman Khan
FAFIROZ AKHTER
FIROZ AKHTER
AKAmir Khan
Amir Khan
JAJ. M. Ashraf
J. M. Ashraf
USUzma Shahab
Uzma Shahab
Glycation is the result of covalent bonding of a free amino group of biological macromolecules with a reducing sugar, which results in the formation of a Schiff base that undergoes rearrangement, dehydration and cyclization to form a more stable Amadori product. The final products of nonenzymatic glycation of biomacromolecules like DNA, proteins and lipids are known as advanced glycation end products (AGEs). AGEs may be generated rapidly or over long times stimulated by distinct triggering mechanisms, thereby accounting for their roles in multiple settings and disease states. Both Schiff base and Amadori glycation products generate free radicals resulting in decline of antioxidant defense mechanisms and can damage cellular organelles and enzymes. This critical review primarily focuses on the mechanistic insight of glycation and the most probable route for the formation of glycation products and their therapeutic interventions. Furthermore, the prevention of glycation reaction using therapeutic drugs such as metformin, pyridoxamine and aminoguanidine (AG) are discussed with special emphasis on the novel concept of the bioconjugation of these drugs like, AG with gold nanoparticles (GNPs). At or above 10 mM concentration, AG is found to be toxic and therefore has serious health concerns, and the study warrants doing this novel bioconjugation of AG with GNPs. This approach might increase the efficacy of the AG at a reduced concentration with low or no toxicity. Using the concept of synthesis of GNPs with abovementioned drugs, it is assumed that toxicity of various drugs which are used at high doses can be minimized more effectively.

1 June 2012 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
BABinish Arif
Binish Arif
JAJalaluddin M. Ashraf
Jalaluddin M. Ashraf
MOMoinuddin
Moinuddin
JAJamal Ahmad
Jamal Ahmad
ZAZarina Arif
Zarina Arif
KAKhursheed Alam
Khursheed Alam

1 June 2015 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JAJalaluddin M. Ashraf
Jalaluddin M. Ashraf
USUzma Shahab
Uzma Shahab
STShams Tabrez
Shams Tabrez
ELEun Ju Lee
Eun Ju Lee
ICInho Choi
Inho Choi
Saheem AhmadSaheem Ahmad
Saheem Ahmad

29 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JAJalaluddin Mohammad Ashraf
Jalaluddin Mohammad Ashraf
Gulam RabbaniGulam Rabbani
Gulam Rabbani
Saheem AhmadSaheem Ahmad
Saheem Ahmad
QHQambar Hasan
Qambar Hasan
RKRizwan Khan
Rizwan Khan
ICInho Choi
Inho Choi
Advanced glycation end products (AGEs) culminate from the non-enzymatic reaction between a free carbonyl group of a reducing sugar and free amino group of proteins. 3-deoxyglucosone (3-DG) is one of the dicarbonyl species that rapidly forms several protein-AGE complexes that are believed to be involved in the pathogenesis of several diseases, particularly diabetic complications. In this study, the generation of AGEs (Nε-carboxymethyl lysine and pentosidine) by 3-DG in H1 histone protein was characterized by evaluating extent of side chain modification (lysine and arginine) and formation of Amadori products as well as carbonyl contents using several physicochemical techniques. Results strongly suggested that 3-DG is a potent glycating agent that forms various intermediates and AGEs during glycation reactions and affects the secondary structure of the H1 protein. Structural changes and AGE formation may influence the function of H1 histone and compromise chromatin structures in cases of secondary diabetic complications.

17 February 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JAJalaluddin M. Ashraf
Jalaluddin M. Ashraf
Saheem AhmadSaheem Ahmad
Saheem Ahmad
Gulam RabbaniGulam Rabbani
Gulam Rabbani
QHQambar Hasan
Qambar Hasan
AJArif Tasleem Jan
Arif Tasleem Jan
ICInho Choi
Inho Choi
Advanced glycation end-products (AGEs) are heterogeneous group of compounds, known to be implicated in diabetic complications. One of the consequences of the Maillard reaction is attributed to the production of reactive intermediate products such as α-oxoaldehydes. 3-deoxyglucosone (3-DG), an α-oxoaldehyde has been found to be involved in accelerating vascular damage during diabetes. In the present study, calf thymus histone H3 was treated with 3-deoxyglucosone to investigate the generation of AGEs (Nε-carboxymethyllysine, pentosidine), by examining the degree of side chain modifications and formation of different intermediates and employing various physicochemical techniques. The results clearly indicate the formation of AGEs and structural changes upon glycation of H3 by 3-deoxyglucosone, which may hamper the normal functioning of H3 histone, that may compromise the veracity of chromatin structures and function in secondary complications of diabetes.